Skip to contentE
Escalon Medical Corp
E
ESMCEscalon Medical Corp Q1 2025 · 10-Q
Revenue$2.78M$2.78M−5.6% vs Q1 2024 Net Income-$32.22K-$32.22KN/M vs Q1 2024 EPS Diluted-$0.01-$0.01— vs Q1 2024 Operating Income-$26,955N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Escalon Medical Corp · CIK 862668 · Engraved from SEC EDGAR
Free Cash Flowderived$33,329N/M Margins · derivedOperating margin-1.0%−0.4 pt vs Q1 2024
Net margin-1.2%−0.4 pt vs Q1 2024
ended Sep 30, 2024 · filed Nov 14, 2024 · 45 d after period end